Virtu Financial’s European Biotech Acquisition Corp. Class A Ordinary Shares EBAC Stock Holding History

Virtu Financial’s Portfolio EBAC Stock Details EBAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,678	Closed	-$199K	–	2444
2022 Q4	$199K	Buy	+19,678	New	+$197K	0.03%	701

Virtu Financial's EBAC Position: Q1 2023 in Review

Virtu Financial sold out of European Biotech Acquisition Corp. Class A Ordinary Shares (EBAC) in Q1 2023, closing a stake of 19,678 shares — an estimated $199K sold.

Virtu Financial first reported a position in EBAC in Q4 2022 and held it in 1 quarter. The position peaked at $199K in Q4 2022. 0 funds tracked by Wall St. Rank hold EBAC as of Q1 2023.

Virtu Financial reported no remaining European Biotech Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Virtu Financial sold 19,678 European Biotech Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $199K.
Virtu Financial first reported a position in European Biotech Acquisition Corp. Class A Ordinary Shares in Q4 2022 and held it in 1 quarter.
Virtu Financial's European Biotech Acquisition Corp. Class A Ordinary Shares position peaked at $199K in Q4 2022.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Virtu Financial's 13F filing for Q1 2023, filed 1 May 2023.